exRNAdisease

Entry Detail

---



General Information

Database ID: exR0356543 RNA Name: hsa-miR-205-5p RNA Type: miRNA Chromosome: chr1 Starnd: + Coordinate: Start Site(bp): 209432166 End Site(bp): 209432187 External Links: hsa-miR-205-5p

Disease Information

Disease Name: Breast Cancer Disease Category: Cancers MeSH ID: D001943 Type: Neoplasms/Breast Neoplasms Alias: Breast Neoplasms//Breast Neoplasm//Neoplasm, Breast//Breast Tumors//Breast Tumor//Tumor, Breast//Tumors, Breast//Neoplasms, Breast//Breast Cancer//Cancer, Breast//Mammary Cancer//Cancer, Mammary//Cancers, Mammary//Mammary Cancers//Malignant Neoplasm of Breast//Breast Malignant Neoplasm//Breast Malignant Neoplasms//Malignant Tumor of Breast//Breast Malignant Tumor//Breast Malignant Tumors//Cancer of Breast//Cancer of the Breast//Mammary Carcinoma, Human//Carcinoma, Human Mammary//Carcinomas, Human Mammary//Human Mammary Carcinomas//Mammary Carcinomas, Human//Human Mammary Carcinoma//Mammary Neoplasms, Human//Human Mammary Neoplasm//Human Mammary Neoplasms//Neoplasm, Human Mammary//Neoplasms, Human Mammary//Mammary Neoplasm, Human//Breast Carcinoma//Breast Carcinomas//Carcinoma, Breast//Carcinomas, Breast

Expression Detail

GEO ID: GSE98181 Description: Circulating miRNA profiles from serum of women at high-risk for breast cancer Experimental Design: Cancer vs Control Case Disease Type: Breast Cancer Case Disease SubType: NA Case Sample: Breast Cancer Control Sample: Healthy Number of Case: 24 Number of Control: 24 Number of Samples: 48

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand DOCK6 chr19 11199295 11262524 - MKRN2 chr3 12557087 12583713 + NUP93 chr16 56730118 56850286 + EP300 chr22 41092592 41180077 + CDC42 chr1 22025511 22101360 + LSM1 chr8 38163335 38176730 - TSPYL4 chr6 116249964 116254075 - HINT1 chr5 131159027 131171735 - YTHDF2 chr1 28736621 28769775 + PPP3CC chr8 22440819 22541142 + SLTM chr15 58879050 58933679 - RUNX1T1 chr8 91954967 92103286 - CALM3 chr19 46601074 46610782 + PRKCSH chr19 11435288 11450968 + SFPQ chr1 35176378 35193145 - PLXNA1 chr3 126988594 127037392 + KAZN chr1 13892792 15118043 + OGDH chr7 44606572 44709066 + ZCCHC8 chr12 122471599 122501073 - SLC25A3 chr12 98593591 98606379 + AFF4 chr5 132875395 132963634 - CAPZA2 chr7 116811070 116922049 + SLC3A2 chr11 62856102 62888875 + ACSL1 chr4 184755595 184826818 - XRCC6 chr22 41621119 41664048 + NDUFAF1 chr15 41387353 41402519 - SOSTDC1 chr7 16461481 16530580 - E2F1 chr20 33675477 33686385 - CCZ1B chr7 6794134 6826770 - GNPDA2 chr4 44682200 44726588 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001434 chr4 106345352 106377902 - hsa_circ_0001731 chr7 100731990 100738448 + hsa_circ_0000733 chr17 1561546 1562030 - lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC009133.5 chr16 29808679 29812227 + GAS5 chr1 173858559 173868882 - MALAT1 chr11 65497688 65506516 + MCM3AP-AS1 chr21 46229196 46259390 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG16 chr17 76557764 76565348 + SNHG5 chr6 85650491 85678932 - AL356133.1 chr9 26801733 26805862 + Display:

Experiment Detail

GEO ID: GSE98181 Sample Source: Blood Source Fraction: Serum Platform: GPL21572 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2546 Sample treatment protocol: Serum is obtained from coagulated whole blood samples by centrifugation at 3000 rpm for 10 minutes. RNA Extract protocol: RNA was isolated from a 200ul serum aliquot using the miRNeasy Serum Plasma kit with ce-miR-39 spike-in (QIAGEN), QIAcube (QIAGEN) automation, and eluted with 14uL of nuclease-free water. RNA library preparation protocol: Exactly 8ul of RNA was tagged with a Poly-A tail, using an ATP driven reaction from the Affymetrix® FlashTag™ Biotin HSR RNA Labeling Kit.

Reference

PMID: 29348816 Title: Development of a predictive miRNA signature for breast cancer risk among high-risk women. Author: Farina NH, Ramsey JE, Cuke ME, Ahern TP, Shirley DJ, Stein JL, Stein GS, Lian JB, Wood ME Journal: Oncotarget. 2017 Nov 28;8(68):112170-112183. Description: We evaluated the ability of C-miRNAs to identify women most likely to develop breast cancer by profiling miRNA from serum obtained long before diagnosis.